Stem Cell Therapy Market Is Expected to Reach USD 60.94 Billion by 2022

The increasing government initiatives and funding from various organizations, the increased spending on research and development, rapid technological advancement in genomics, and the rising awareness about the stem cell therapy are some of the factors fuelling the growth of the stem cell therapy market.

Logo

Chicago, IL -- (SBWire) -- 02/16/2017 --According to the new market research report, "Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), Applications (Central Nervous System Diseases, Eye Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Gastrointestinal Disorders and Immune System Disorders), End-users (Hospitals and Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global stem cell therapy market is expected to grow from USD 11.99 billion in 2016 and reach USD 60.94 billion by 2022, growing at a CAGR of 31.1% from 2016 to 2022.

The global stem cell therapy market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/stem-cell-therapy-market

Buyers can expect to receive 100% customization on this report.
Key findings of the report:
Growth in demand, increased government initiatives and funding and increased research and development activities are some of the major driving factors for the stem cell therapy market.
The advanced technologies in genomics and the rapidly increasing awareness towards stem cell therapy are also some of the key drivers for the stem cell therapy market.

The rising demand from the emerging markets is also expected to create growth opportunities for the key players in the stem cell therapy market.

North America is expected to dominate the stem cell therapy market
According to the report, the North America region is expected to hold the largest share in the global stem cell therapy market. The report attributes this growth of the market to the increasing government initiatives, rapid technological advancements, huge investments in research and development, fast-track FDA approvals, and the rapid developments in the genomic methods. The report expects the Asia-Pacific region to witness the fastest growth during the forecast period.

Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=178

The report analyzes some of the key players in the stem cell therapy market, which include:
Celgene Corporation
Stemcells, Inc.
Mesoblast Ltd.
Vericel Corporation
ReNeuron Group Plc
Regeneus Ltd.
Fibrocell Science, Inc.
Gamida Cell
Cytori Therapeutics, Inc.
International Stem Cell Corporation

Browse Related Reports:
Medical Robotics Market, by Application (Neurology, Laparoscopy, Cardiology, Orthopedic, Special Education), Product (Robotic Systems, Instruments & Accessories) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
https://www.scalarmarketresearch.com/market-reports/medical-robotics-market

Dermatology Devices Market, by Diagnostic Devices (Dermatoscopes, Microscopes, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Cryotherapy, Electrosurgical, Light Therapy Devices, Lasers), Applications (Cancer Diagnosis, Wrinkle Removal, Skin Rejuvenation, Skin Resurfacing, Vascular Lesions, Acne, Psoriasis, Hair Removal) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
https://www.scalarmarketresearch.com/market-reports/dermatology-devices-market

About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.
Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, work relentlessly to help our clients realize their most important business goals.
Find out more about our services at: http://www.scalarmarketresearch.com

Contact:
Mr. Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email:sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research

Media Relations Contact

Moses Nakka
Vice President -- Marketing
Scalar Market Research
1-800-213-5170
https://www.scalarmarketresearch.com/market-reports/stem-cell-therapy-market

View this press release online at: http://rwire.com/771849